Navigation Links
Biopharmaceutical Success Depends on Delivery, Fueling $7.8 BN Market: Report
Date:11/16/2018

A promising new product can flounder if patients don't comply, and companies are thinking about delivery systems that can improve compliance early in the development of new drugs. Market research firm Kalorama Information said that the total market for biopharmaceutical drug delivery devices is estimated at $7.8 billion, boosted by developments in implants, pumps, and microfluidics, as well as needle-free injectors. That's according to a new report from Kalorama, World Market for Biopharmaceutical Drug Delivery Device Technology. https://www.kaloramainformation.com/Biopharmaceutical-Drug-Delivery-Device-Technology-12013625/.

Kalorama said that nearly 70% of drugs approved for the marketplace this year will be the result of biotechnology. It's the area of fastest revenue growth in the pharmaceutical industry, growing at an average rate of 12%-15% over the past two years. Sales of select biopharmaceuticals have been brisk: Enbrel $7.8 billion, Remicade $8.1billion, Humira $18.6 billion, and Avastin $6.8 billion for 2017. The continued expansion of biotechnology and gene therapy has resulted in an increased use of proteins, peptides, and genes in the treatment of diseases, where delivery strategies are challenging and critical.

"A new biopharmaceutical may be a potential blockbuster but if it does not have an easy patient-friendly delivery method, that potential will not be realized, because there will be compliance problems," said Bruce Carlson, Publisher of Kalorama Information. "Biopharma is looking at user-friendly pens, jets, patches and other systems to enhance their compliance and breathe new life into their existing products."

Pfizer, for instance, is a leading provider of needle-free drug delivery technology for vaccines. The company offers the Particle Mediated Epidermal Delivery (PMED) technology, a needle- free delivery system that delivers DNA-coated microscopic gold particles into the skin using pressurized helium gas.

"The use of this technology in both prophylactic and therapeutic vaccines has had a substantial impact on Pfizer’s growing market share," Carlson said.

Needle-free is a significant area of development covered in Kalorama's report. To reduce the risk of needle-stick injuries, needle-free admixture systems can be packaged in the kit with the biotherapeutic and prefilled syringe. To improve speed to market for these systems, a number of contract manufacturing companies have established their own diluent syringe master files that can be referenced by the pharmaceutical company buyer. Because patients’ compliance may be increased with seamless self-administration of injectables, other improvement to drug delivery technology includes the use of autoinjectors and cartridge pens. For biologics, the time to market with a prefilled syringe is shorter than in a vial form.

Kalorama Information's report provides market sizing and forecasting for several categories of drug delivery, sorts out the competitive advantages of various delivery improvements, and makes forecasts for revenues earned by delivery device providers. The report also covers companies who specialized in delivery. The report is available at: https://www.kaloramainformation.com/Biopharmaceutical-Drug-Delivery-Device-Technology-12013625/

About Kalorama Information

Kalorama Information, a division of BioInformatics Inc., supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog on our company website: https://www.kaloramainformation.com/.

Media Contact:
Bruce Carlson
212-807-2262
bruce.carlson(at)kaloramainformation.com

Read the full story at https://www.prweb.com/releases/2018/11/prweb15925388.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine news :

1. Accelerated Biopharmaceutical Development through Strategic Analytical Partnerships to be Discussed by Catalent Expert at Upcoming WCBP Conference
2. Reliable Biopharmaceutical Announces New Investor and Chairman
3. FDAnews Announces — The Biopharmaceutical Facility of the Future: To 2025 and Beyond Webinar, Sept. 29, 2015
4. Dr. Kevin Sadati Discusses the Impact of Allergan Acquiring KYTHERA Biopharmaceuticals
5. Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc.
6. Keryx Biopharmaceuticals receives FDA approval of ferric citrate
7. Biopharmaceuticals - A Global Market Overview
8. Focused on Customer Success, Greenway Health Announces the Appointment of Kimberly O’Loughlin to President
9. NACDD Celebrates Diabetes Awareness Month: Shares Successes from Groundbreaking Diabetes Prevention
10. Canada Drug Rehab, Canada's Leading Directory of Alcohol Treatment and Drug Rehab Programs from Vancouver to Toronto, Announces National Recovery Month Success
11. SuccessTMS Brings Breakthrough Transcranial Magnetic Stimulation Treatment to West Palm Beach, Pledges to Treat One Million Patients in Honor of Founder’s Sister
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2019)... ... 2019 , ... Women’s Excellence is pleased to announce the opening of their ... Turrill Road and South Lapeer Roads, conveniently off I-69 in Lapeer. , “We are ... service women in this community. We’ve dedicated a great team of physicians and nurse ...
(Date:10/15/2019)... ... October 14, 2019 , ... Khalieghya Dandie-Evans, a liver transplant recipient from Richmond, ... Life Rose Parade® float in the 131st Rose Parade® on New Year’s Day. She ... California and Northern Nevada, the organization’s service area. , Khalieghya, 17, grew up believing ...
(Date:10/15/2019)... ... October 15, 2019 , ... Nashville Fertility Center (NFC) ... latest fertility doctor to join the practice. In addition to treating general infertility, Dr. ... , The team at NFC looks forward to Dr. Van Heertum joining the practice ...
(Date:10/10/2019)... , ... October 10, 2019 , ... ... consulting and information technology (IT) services for the healthcare industry, has completed the ... Hospitals Authority (PHA) of the Commonwealth of The Bahamas towards a fully integrated ...
(Date:10/8/2019)... ... October 08, 2019 , ... SoCal Adolescent Wellness announces the opening of ... expansion of our services to better serve the families in Orange County," said Becca ... to see the extraordinary impact this pre-intervention program has on the lives of the ...
Breaking Medicine News(10 mins):
(Date:10/19/2019)... ... ... Hospital M&A activity held steady with 21 transactions in both the second and ... quarter was down 20% compared with the same period in 2018, when 25 deals ... $5.0 billion, a 291% increase. Year over year, Q3:19 spending was down 41% versus ...
(Date:10/17/2019)... , ... October 17, 2019 , ... The findings of ... illness in the individuals studied could be caused by toxic chemicals rather than the ... Pulmonary Illness Associated With E-Cigarette Use (Vaping): A Report of Eight Cases ,” by ...
(Date:10/15/2019)... ... October 15, 2019 , ... Twiggy Bean, Ph.D., wanted to educate ... embittered divorce battles make better decisions and become truly child focused. This objective prompted ... be resilient, and STOP the cycle! Don’t be a divorce bully!” (published by Balboa ...
Breaking Medicine Technology: